SCHEMBL5772823

SCHEMBL5772823

O=C(O)NS(=O)(=O)N(c1ccccc1)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.44
PKM P14618 1/20 0.42
NPSR1 Q6W5P4 2/20 0.41
ALDH1A1 P00352 2/20 0.39
ACP1 P24666 2/20 0.37
HPGD P15428 1/20 0.36
HSP90AA1 P07900 1/20 0.36
PTGES O14684 1/20 0.36
TSHR P16473 1/20 0.36
NR3C2 P08235 1/20 0.36
NPC1 O15118 1/20 0.35
POLB P06746 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27561867 0.84 MEN1 (0.49) ESR1PKMNPSR1ALDH1A1ACP1
SCHEMBL29223932 0.74 KEAP1 (0.52) ESR1PKMALDH1A1HPGDNR3C2
SCHEMBL7085689 0.72 CA2 (0.55) NPSR1ALDH1A1NPC1POLBHTT
SCHEMBL129629 0.71 PKM (0.56) ESR1PKMNPSR1ALDH1A1HSP90AA1
SCHEMBL10861402 0.71 CA1 (0.43) NPSR1ALDH1A1TSHRPOLBKMT2A
SCHEMBL10861406 0.71 CA1 (0.43) NPSR1ALDH1A1TSHRPOLBKMT2A
SCHEMBL6866672 0.71 HPGD (0.61) ALDH1A1HPGDNR3C2HTTKMT2A
SCHEMBL450584 0.70 ESR1 (0.52) ESR1PKMNPSR1ALDH1A1HPGD
SCHEMBL7085174 0.70 NLRP3 (0.43)
SCHEMBL11322994 0.69 ESR1 (0.50) ESR1PKMNPSR1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0592439-B1 AMINOSULFONYL CARBAMATES WARNER LAMBERT CO (US) 2003-07-30 EP claimed
EP-0931078-B1 NOVEL TRICYCLIC PIPERIDINYL COMPOUNDS USEFUL AS INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE SCHERING CORP (US) 2006-11-15 EP disclosed
EP-0934303-B1 COMPOUNDS USEFUL FOR INHIBITION OF FARNESYL PROTEIN TRANSFERASE SCHERING CORP (US) 2004-12-29 EP disclosed
EP-0927178-B1 TRICYCLIC COMPOUNDS USEFUL FOR INHIBITION OF G-PROTEIN FUNCTION AND FOR TREATMENT OF PROLIFERATIVE DISEASES SCHERING CORP (US) 2002-02-27 EP disclosed
US-5965570-A PHARMACEUTICAL COMPOSITIONS FOR INHIBITING THE ABNORMAL GROWTH OF CELLS; ADMINISTERING TO INHIBIT TUMOR CELLS WHEREIN THE RAS PROTEIN IS ACTIVATED AS A RESULT OF ONCOGENIC MUTATION IN GENES OTHER THAN THE RAS GENE SCHERING CORPORATION (US) 1999-10-12 US disclosed
US-5958890-A ANTITUMOR SCHERING CORPORATION (US) 1999-09-28 US disclosed
EP-0934303-A2 COMPOUNDS USEFUL FOR INHIBITION OF FARNESYL PROTEIN TRANSFERASE SCHERING CORPORATION (US) 1999-08-11 EP disclosed
EP-0931078-A1 NOVEL TRICYCLIC PIPERIDINYL COMPOUNDS USEFUL AS INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE SCHERING CORPORATION (US) 1999-07-28 EP disclosed
US-5861395-A ENZYME INHIBITORS FOR BREAST TUMOR CELLS SCHERING CORPORATION (US) 1999-01-19 US disclosed
WO-1998011091-A2 TRICYCLIC COMPOUNDS USEFUL FOR INHIBITION OF FARNESYL PROTEIN TRANSFERASE SCHERING CORPORATION (US) 1998-03-19 WO disclosed
WO-1998011098-A1 NOVEL TRICYCLIC PIPERIDINYL COMPOUNDS USEFUL AS INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE SCHERING CORPORATION (US) 1998-03-19 WO disclosed